Cooperman’s Strategic Moves in the Last Quarter of 2024 ?
In the final quarter of 2024, Leon Cooperman’s Omega Advisors made significant adjustments to its investment portfolio. The billionaire investor took the opportunity to increase his holdings in a few lesser-known companies that faced challenges during this period. These strategic decisions reflect his confidence in the potential rebound of these assets. He specifically augmented his stakes in WillScot Holdings, Ashland, and Elevance Health, moving these companies into the top tiers of his investment portfolio as per the latest regulatory filings.
Investing in WillScot Holdings ?
Cooperman’s investment in WillScot Holdings showed a notable increase. He raised his stake in the storage solutions provider by approximately $14 million, equating to a 10.5% uptick, bringing his total investment to over $130 million. This growth in position now positions WillScot as the fifth largest investment within Cooperman’s portfolio. Despite experiencing an 11% decline over the fourth quarter, marking its third consecutive quarterly loss, shares of WillScot have since rebounded by more than 12% in 2025, signaling resilience.
Subscribe to our Social Media for Exclusive Crypto News and Insights 24/7!
Boosting Ashland Holdings ️
Alongside his stake in WillScot, Cooperman also bolstered his investment in Ashland, a chemical company known for its critical role in various industrial sectors. His investment in Ashland grew by over 33%, amounting to an additional $29 million, bringing the total to nearly $104 million. This adjustment now ranks Ashland as the ninth largest holding within Omega’s portfolio. The company faced a more significant setback, with shares falling close to 18% in the fourth quarter, leading to its third consecutive decline. As of the first quarter of 2025, Ashland already faced a further drop of around 9.2%, contrasting the upward momentum seen in WillScot Holdings.
Occupying a Position in Elevance Health ?
Elevation Health is another company that caught Cooperman’s interest, resulting in an increase of nearly 63% in his holdings, which translates to an infusion of $50 million. His total investment in Elevance Health is now valued at over $102 million. This led Elevance Health to be the fund’s tenth largest position by the end of 2024. However, the health insurer also grappled with challenges, experiencing a substantial decline of just over 29% in the fourth quarter. This slump came on the heels of a 4% decrease noted in the prior quarter. Recent trends indicate a recovery, as Elevance shares have subsequently appreciated by over 5% in 2025.
Analyst Outlook for the Future ?
Despite the hardships faced by these stocks, the general sentiment on Wall Street remains optimistic. More than half of the analysts surveyed by LSEG currently recommend a buy rating for each of the three companies highlighted. Analysts’ average price targets reflect positive outlooks, suggesting a potential upside for these stocks in the near future.
Summary ?
In summary, Leon Cooperman’s strategic investment choices during the fourth quarter of 2024 highlight his belief in WillScot Holdings, Ashland, and Elevance Health as valuable assets for his portfolio. Each company, while struggling in the short term, shows signs of recovery and optimism from analysts which could indicate better performance ahead. This year, as Cooperman demonstrates increased commitment to these firms, the market watches closely for signs of long-term growth.
